By Iain Gilbert
Date: Wednesday 27 Aug 2025
(Sharecast News) - Pre-clinical antibody discovery specialists Fusion Antibodies said on Wednesday that it has been selected for three follow-on projects to its existing stable Cell Line Development project.
Holding(s) in Company | 29-Aug-2025 | 09:25 | RNS |
Director/PDMR Shareholding | 29-Aug-2025 | 09:10 | RNS |
Transaction in Own Shares | 29-Aug-2025 | 07:00 | RNS |
Transaction in Own Shares | 29-Aug-2025 | 07:00 | RNS |
Form 8.3 - Primary Health property | 28-Aug-2025 | 13:44 | RNS |
Investment Column:Consort Medical | 02-Dec-2011 | The Independent |
Investment Column:Lidco | 27-Oct-2011 | The Independent |
FTSE live: London steady; Burberry down | 14-Mar-2011 | Daily Mail |
FTSE close: Tesco up; Mining shares surge | 08-Dec-2010 | Daily Mail |
Investment Column : Lidco | 27-Oct-2010 | The Independent |
Price | 10,502.03 |
Closing Price Change | -237.61 |
% Change | -2.21 % |
28-Aug-25 Close | 10,502.03 |
You are here: research